These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31309777)

  • 1. Tophi reduction: ultrasound imaging and correlation with plasma levels of uric acid in patients undergoing treatment for tophaceous gout.
    Ferrari AJL; Corrêa Fernandes AR; De Almeida Agustinelli R; Seike H; De Ávila Fernandes E
    Reumatismo; 2019 Jul; 71(2):75-80. PubMed ID: 31309777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking.
    Modjinou DV; Krasnokutsky S; Gyftopoulos S; Pike VC; Karis E; Keenan RT; Lee K; Crittenden DB; Samuels J; Pillinger MH
    Clin Rheumatol; 2017 Sep; 36(9):2101-2107. PubMed ID: 28623421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of plain radiography for assessing hypouricemic treatment response in patients with tophaceous gout.
    Suh YS; Cheon YH; Kim JE; Kim JM; Kim SH; Lee WS; Yoo WH; Lee SI; Kim HO
    Int J Rheum Dis; 2016 Nov; 19(11):1183-1188. PubMed ID: 27514938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
    Mandell BF; Yeo AE; Lipsky PE
    Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musculoskeletal Ultrasound in Monitoring the Efficacy of Gout: A Prospective Study Based on Tophus and Double Contour Sign.
    Yuan H; Fan Y; Mou X; Qing Y; Yan X; Tang X; Yue W; Gu P; Yang Q; He Y
    Balkan Med J; 2023 Mar; 40(2):104-110. PubMed ID: 36715053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic measurement of tophi as an outcome measure for chronic gout.
    Perez-Ruiz F; Martin I; Canteli B
    J Rheumatol; 2007 Sep; 34(9):1888-93. PubMed ID: 17659752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy.
    Cao C; Gamble G; Horne A; Aati O; Doyle A; Drake J; Stamp LK; Dalbeth N
    Rheumatology (Oxford); 2024 May; 63(6):1539-1542. PubMed ID: 37688559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment.
    Peiteado D; Villalba A; Martín-Mola E; Balsa A; De Miguel E
    Clin Exp Rheumatol; 2017; 35(5):746-751. PubMed ID: 28281462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gouty tophus: a review.
    Chhana A; Dalbeth N
    Curr Rheumatol Rep; 2015 Mar; 17(3):19. PubMed ID: 25761926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound in gout: a useful tool for following urate-lowering therapy.
    Ottaviani S; Gill G; Aubrun A; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2015 Jan; 82(1):42-4. PubMed ID: 25543275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of ultrasound-detected tophi in patients with gout.
    Lu B; Lu Q; Huang B; Li C; Zheng F; Wang P
    Clin Rheumatol; 2020 Jun; 39(6):1953-1960. PubMed ID: 32062769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.
    Ma L; Sun R; Jia Z; Zou Y; Xin Y; Cheng X; Liu T; Cui L; Liu Z; Wu X; Li C
    Clin Rheumatol; 2018 May; 37(5):1359-1365. PubMed ID: 29354873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
    Christensen HD; Sheta HM; Morillon MB; Hansen IM
    Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of uric acid depositing in tophaceous gout using a new dual energy spectral CT technology.
    Li X; Wang X; Yu Y; Liu B; Cai J; Xia L; Luo L; Wang W; Ding Q; Zhang C; Wang J
    J Xray Sci Technol; 2014; 22(4):541-9. PubMed ID: 25080120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).
    Aati O; Taylor WJ; Siegert RJ; Horne A; House ME; Tan P; Drake J; Stamp LK; Dalbeth N
    Ann Rheum Dis; 2015 Dec; 74(12):2144-50. PubMed ID: 25114061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic tophaceous gout with unusual large tophi: case report.
    Aradoini N; Talbi S; Berrada K; Abourazzak FZ; Harzy T
    Pan Afr Med J; 2015; 22():132. PubMed ID: 26889313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between urate within tophus and bone erosion according to the anatomic location of urate deposition in gout: A quantitative analysis using dual-energy CT volume measurements.
    Shi D; Chen JY; Wu HX; Zhou QJ; Chen HY; Lu YF; Yu RS
    Medicine (Baltimore); 2019 Dec; 98(51):e18431. PubMed ID: 31861011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
    Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
    J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.